Fichorova, R.N., Trifonova, R.T., Gilbert, R.O., Costello, C.E., Hayes, G.R., Lucas, J.J., Singh, B.N. (2006) Trichomonas vaginalis Lipophosphoglycan Triggers a Selective Upregulation of Cytokines by Human Female Reproductive Tract Epithelial Cells. Infection and Immunity. 74(10): 5773–5779.
Willett, C.G., Boucher, Y., Duda, D.G., di Tomaso, E., Munn, L.L., Tong, R.T., Petit, L., Chung, D.C., Sahani, D.V., Kalva, S.P., Kozin, S.V., Cohen, K.S., Scadden, D.T., Fischman, A.J., Clark, J.W., Ryan, D.P., Zhu, A.X., Blaszkowsky, L.S., Shellito, P.C., Mino- Kenudson, M., Lauwers, G.Y., Jain, R.K. (2005) A Study of High– Versus Low-Dose-Bevacizumab in Combination with Local Radiotherapy and 5-Flourouracil Chemotherapy in a Phase I Trial for Patients with Locally Advanced Rectal Cancer. In Press.
Phelps, T., Anthes, J.C., Correll, C.C. (2006) Characterization of adenosine receptors in the human bladder carcinoma T24 cell line. European Journal of Pharmacology. 536(1-2): 28-37.
Tew, D.J., Johnson, J.K., Maxey, K.M. (2005) Platforms for Eicosanoid Measurements. Genetic Engineering News. 25(20): 34.
Willett, C.G., Boucher, Y., Duda, D.G., di Tomaso, E., Munn, L.L., Tong, R.T., Kozin, S.V., Petit, L., Jain, R.K., Chung, D.C., Sahani, D.V., Kalva, S.P., Cohen, K.S., Scadden, D.T., Fischman, A.J., Clark, J.W., Ryan, D.P., Zhu, A.X., Blaszkowsky, L.S., Shellito, P.C., Mino-Kenudson, M., Lauwers, G.Y. (2005) Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. Journal of Clinical Oncology. 23(31): 8136-8139.
Moxness, M., Tatarewicz, S., Weeraratne, D., Murakami, N., Wullner, D., Mytych, D., Jawa, V., Koren, E., Swanson, S.J. (2005) Immunogenicity Testing by Electrochemiluminescent Detection for Antibodies Directed against Therapeutic Human Monoclonal Antibodies. Clinical Chemistry. 51: 1983-1985.
Vieira, O.V., Verkade, P., Manninen, A., Simons, K. (2005) FAPP2 is involved in the transport of apical cargo in polarized MDCK cells. The Journal of Cell Biology. 170(4): 521-526.
Hu, W., Ranaivo, H.R., Craft, J.M., Van Eldik, L.J., Watterson, D.M. (2005) Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimer's Disease-Related Mouse Model. Current Alzheimer's Research. 2(2): 197-205.
Davydov, I.V., Woods, D., Safiran, Y.J., Oberoi, P., Fearnhead, H.O., Fang, S., Jensen, J.P., Weissman, A.M., Kenten, J.H., Vousden, K.H. (2004) Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2. Journal of Biomolecular Screening. 9(8): 695-703.
Yang, Y., Ludwig, R.L., Jensen, J.P., Pierre, S.A., Medaglia, M.V., Davydov, I.V., Safiran, Y.S., Oberoi, P., Kenten, J.H., Phillips, A.C., Weissman, A.M., and Vousden, K.H. (2005) Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell. 7(6): 547-549.
Best, J.D., Jay, M.T., Out, F., Ma, J., Nadin, A., Ellis, S., Lewis, H.D., Pattison, C., Reilly, M., Harrison, T., Shearman, M.S., Williamson, T.L., and Atack, J.R. (2005) Quantitative measurement of changes in Ab40 in the rat brain and CSF following treatment with the g-secretase inhibitor, N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5Hdibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575). Journal of Pharmacology and Experimental Therapeutics. 313(2): 902-908.
Freebern, W.J., Haggerty, C.M., Montano, I., McNutt, M.C., Collins, I., Graham, A., Chandramouli, G.V.R., Stewart, D.H., Biebuyck, H.A., Taub, D.D., Gardner, K. (2005) Pharmacologic profiling of transcriptional targets deciphers promoter logic. The Pharmacogenomics Journal. 5(5): 305-323
Kenten J.H., Davydov I.V., Safiran Y.J., Stewart D.H., Oberoi P., and Biebuyck H.A. (2005) Assays for high-throughput screening of E2 and E3 ubiquitin ligases. Methods in Enzymology, 399: 682-701.
Davydov I.V., Kenten J.H., Safiran Y.J., Nelson S. Swenerton R., Oberoi P., and Biebuyck H.A. (2005) In vitro screening for substrates of the N-end rule-dependent ubiquitylation. Methods in Enzymology, 399: 415-432.
Debad, J.D., Glezer, E.N., Wohlstadter, J.N., Sigal, G.B. (2004) Clinical and Biological Applications of ECL. In Electrogenerated Chemiluminescence, ed. A.J. Bard. Marcel Dekker, New York, pp. 43-78.
 
Bard, A.J., Debad, J.D., Leland, J.K., Sigal, G.B., Wilbur, J.L., Wohlstadter, J.N. (2000) Chemiluminescence, Electrogenerated. In Encyclopedia of Analytical Chemistry, ed. R.A. Meyers. John Wiley & Sons, Chichester, pp. 9842-9849.






Browse by product type, species, and/or keywords:

Keyword: